title: Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure.
abstract: BACKGROUND
  In experimental heart failure animal models, remodeling of skeletal and cardiac muscle ryanodine receptors (RyR), including phosphorylation, S-nitrosylation and oxidation, have been reported to contribute to pathologic Ca2+ release, impaired muscle function and fatigue. However, it is not known whether similar remodeling of RyR1 in skeletal muscle occurs in patients with heart failure, and if this is associated with impairment of physical activity.
  
  
  METHODS
  We studied 8 sedentary patients with New York Heart Association (NYHA) Class III heart failure and 7 age-matched, healthy, but sedentary controls. All heart failure patients had NYHA Class III and peak VO2, echocardiography and NT-proBNP data consistent with moderate to severe heart failure. The age-matched controls included were allowed hypertension but sub-clinical heart failure was to have been ruled out by normal peak VO2, echocardiography and NT-proBNP.
  
  
  RESULTS
  Exercise capacity (VO2max) differed by almost 2-fold between heart failure patients and age-matched controls. Compared with controls, skeletal muscle RyR1 in heart failure patients was excessively phosphorylated, S-nitrosylated and oxidized. Furthermore, RyR1 from heart failure patients was depleted of its stabilizing protein FK 506-binding protein 12 (FKBP12, or calstabin1).
  
  
  CONCLUSIONS
  For the first time we show that skeletal muscle RyR1 from human heart failure is post-translationally modified, which corroborates previous data from experimental animal studies. This indicates pathologic Ca2+ release as a potential mechanism behind skeletal muscle weakness and impaired exercise tolerance in patients with heart failure and suggests a potential target for pharmacologic intervention.
authors: Department of Cardiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
authors: Eric
authors: E
authors: Rullman
authors: Daniel C
authors: DC
authors: Andersson
authors: Michael
authors: M
authors: Melin
authors: Steven
authors: S
authors: Reiken
authors: Donna M
authors: DM
authors: Mancini
authors: Andrew R
authors: AR
authors: Marks
authors: Lars H
authors: LH
authors: Lund
authors: Thomas
authors: T
authors: Gustafsson
mesh_terms: D000368:Aged; D001706:Biopsy; D016022:Case-Control Studies; D015897:Comorbidity; D004452:Echocardiography; D017079:Exercise Tolerance / Q000502:physiology*; D005260:Female; D006333:Heart Failure / Q000453:epidemiology / Q000378:metabolism* / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000378:metabolism; D010101:Oxygen Consumption / Q000502:physiology; D010446:Peptide Fragments / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D010446:Peptide Fragments; D019837:Ryanodine Receptor Calcium Release Channel; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain
keywords: ageing; muscle fatigue activity; physical exercise capacity calcium oxidative stress; post-translational contraction; protein processing
references: J Cell Biol. 2003 Mar 17;160(6):919-28
references: 12629052
references: Cell Metab. 2011 Aug 3;14(2):196-207
references: 21803290
references: Circulation. 1983 Aug;68(2):425-32
references: 6861318
references: Skelet Muscle. 2012 May 28;2(1):9
references: 22640601
references: Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):637-42
references: 21268774
references: Physiol Rev. 2008 Jan;88(1):287-332
references: 18195089
references: N Engl J Med. 2003 May 15;348(20):2007-18
references: 12748317
references: J Clin Invest. 2010 Dec;120(12):4375-87
references: 21099115
references: Circulation. 1991 Mar;83(3):778-86
references: 1999029
references: FASEB J. 2003 Aug;17(11):1517-9
references: 12824280
references: Annu Rev Biochem. 2007;76:367-85
references: 17506640
references: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9607-12
references: 15972811
references: J Physiol. 2012 Dec 15;590(24):6381-7
references: 23070698
references: Cell. 2000 May 12;101(4):365-76
references: 10830164
references: J Am Coll Cardiol. 1996 Nov 1;28(5):1092-102
references: 8890800
references: Drug Discov Today Dis Mech. 2010 Summer;7(2):e151-e157
references: 21113427
references: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2198-202
references: 18268335
references: FASEB J. 2008 Nov;22(11):3919-24
references: 18687806
references: Circ Res. 1993 Aug;73(2):405-12
references: 8330383
references: Circulation. 2003 Jan 28;107(3):477-84
references: 12551874
references: N Engl J Med. 1984 Sep 27;311(13):819-23
references: 6382011
references: Nat Med. 2009 Mar;15(3):325-30
references: 19198614
references: Am J Cardiol. 1984 May 1;53(9):1308-15
references: 6711433
references: Circulation. 2003 May 20;107(19):2459-66
references: 12743001
references: J Physiol. 2011 Apr 1;589(Pt 7):1791-801
references: 21486840